Varicella Zoster Vaccine

ApprovedVaccine

UUS Department of Veterans Affairs

Varicella Zoster Vaccine is one of 63 biologic programs targeting Rheumatoid Arthritis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Rheumatoid ArthritisActive, not recruiting

PsoriasisActive, not recruiting

Rheumatoid ArthritisPhase 2

Active, not recruiting

PsoriasisApproved

Active, not recruiting

Competition

Competitive Landscape

791 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

Varicella Zoster Vaccine

UUS Department of Veterans Affairs

Approved

1 2

Rituxan

Roche

Preclinical

61 3

Orencia

Bristol-Myers Squibb

Preclinical

47 4

Actemra

Remicade

43 6

Arcoxia

Novartis

Preclinical

4 7

Actos

Takeda

Preclinical

2 8

Zelhou

Jiangsu Simcere Pharmaceutical Co., Ltd.

Preclinical

7 9

Kineret

SSwedish Orphan Biovitrum

Preclinical

6 10

Rituxan

Pfizer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Rheumatoid Arthritis1 trial

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

Active, not recruiting·KKevin Winthrop·Phase 2·NCT03604406·154 enrolled

Prevention1 trial

Shingles Prevention Study

Completed·UUS Department of Veterans Affairs·Phase 3·NCT00007501·38,456 enrolled

Psoriasis1 trial

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Terminated·IInnovaderm Research Inc.·Phase 4·NCT02408159·3 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Varicella Zoster Vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Varicella Zoster Vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Varicella Zoster Vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — US Department of Veterans Affairs company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: UUS Department of Veterans Affairs

Varicella Zoster Vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Rheumatoid Arthritis1 trial

Prevention1 trial

Psoriasis1 trial

References

Drug Info

Quick Facts

Related News